EPO Patent Publication: Pharmaceutical Composition for Reducing Scalp Sebum Production
Summary
The European Patent Office has published patent application EP4709188A1 for a pharmaceutical composition designed to reduce scalp sebum production. The application lists Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC as the applicant.
What changed
The European Patent Office (EPO) has published patent application EP4709188A1, detailing a pharmaceutical composition aimed at reducing sebum production on the scalp. The publication includes details on the applicants, inventors, and International Patent Classification (IPC) codes related to cosmetic and pharmaceutical compositions. This publication represents a new patent application, not a regulatory rule with compliance obligations.
As this is a patent publication, there are no immediate compliance deadlines or required actions for regulated entities. However, companies in the pharmaceutical and cosmetic sectors may wish to review the patent details for competitive intelligence or potential licensing opportunities. The patent is designated for several European countries, including AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR.
Archived snapshot
Mar 25, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
PHARMACEUTICAL OR COSMETIC COMPOSITION FOR REDUCING SEBUM PRODUCTION ON THE SCALP
Publication EP4709188A1 Kind: A1 Mar 18, 2026
Applicants
Société d'Exploitation de Produits pour les
Industries Chimiques SEPPIC
Inventors
KERN, Catherine, DUDONNE, Stéphanie, FOUILLAND, Julien
IPC Classifications
A23L 7/10 20160101AFI20260205BHEP A61K 8/92 20060101ALI20260205BHEP A61K 8/9783 20170101ALI20260205BHEP A61P 17/08 20060101ALI20260205BHEP A61K 8/55 20060101ALI20260205BHEP A61Q 5/00 20060101ALI20260205BHEP A61K 8/68 20060101ALI20260205BHEP A61K 8/60 20060101ALI20260205BHEP A61K 8/34 20060101ALI20260205BHEP A61K 31/16 20060101ALI20260205BHEP A61K 31/35 20060101ALI20260205BHEP A61K 31/37 20060101ALI20260205BHEP A61K 31/41 20060101ALI20260205BHEP A61K 31/45 20060101ALI20260205BHEP A61K 31/52 20060101ALI20260205BHEP A61K 31/66 20060101ALI20260205BHEP A61K 31/685 20060101ALI20260205BHEP A61K 31/7004 20060101ALI20260205BHEP A61K 33/04 20060101ALI20260205BHEP A61K 33/34 20060101ALI20260205BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Get daily alerts for EPO Patent Bulletin - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.